Note*: This report requires 7-10 business days to complete.
DelveInsight’s Postmenopausal Vaginal Atrophy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Postmenopausal Vaginal Atrophy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Postmenopausal Vaginal Atrophy till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Postmenopausal Vaginal Atrophy market.
• Identifying patient populations in the global “Postmenopausal Vaginal Atrophymarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Postmenopausal Vaginal Atrophy therapeutics in each of the markets covered.
• To understand the future market competition in the global Postmenopausal Vaginal Atrophy therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Postmenopausal Vaginal Atrophy for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Postmenopausal Vaginal Atrophy overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Postmenopausal Vaginal Atrophy Market
• Global Epidemiology of Postmenopausal Vaginal Atrophy Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Postmenopausal Vaginal Atrophy Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Postmenopausal Vaginal Atrophy (2013-2023)
• Table 7: Postmenopausal Vaginal Atrophy Global Market (USD Millions), (2013-2015)
• Table 8: Postmenopausal Vaginal Atrophy Global Market (USD Millions), (2016-2023)
• Table 9: Postmenopausal Vaginal Atrophy US Market (USD Millions), (2013-2015)
• Table 10: Postmenopausal Vaginal Atrophy US Market (USD Millions), (2016-2023)
• Table 11: Postmenopausal Vaginal Atrophy Germany Market (USD Millions), (2013-2015)
• Table 12: Postmenopausal Vaginal Atrophy Germany Market (USD Millions), (2016-2023)
• Table 13: Postmenopausal Vaginal Atrophy United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Postmenopausal Vaginal Atrophy United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Postmenopausal Vaginal Atrophy France Market (USD Millions), (2013-2015)
• Table 16: Postmenopausal Vaginal Atrophy France Market (USD Millions), (2016-2023)
• Table 17: Postmenopausal Vaginal Atrophy Italy Market (USD Millions), (2013-2015)
• Table 18: Postmenopausal Vaginal Atrophy Italy Market (USD Millions), (2016-2023)
• Table 19: Postmenopausal Vaginal Atrophy Spain Market (USD Millions), (2013-2015)
• Table 20: Postmenopausal Vaginal Atrophy Spain Market (USD Millions), (2016-2023)
• Table 21: Postmenopausal Vaginal Atrophy Japan Market (USD Millions), (2013-2015)
• Table 22: Postmenopausal Vaginal Atrophy Japan Market (USD Millions), (2016-2023)
• Table 23: Postmenopausal Vaginal Atrophy ROW Market (USD Millions), (2013-2015)
• Table 24: Postmenopausal Vaginal Atrophy ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Postmenopausal Vaginal Atrophy Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Postmenopausal Vaginal Atrophy (2013-2023)
• Figure 3: Postmenopausal Vaginal Atrophy Global Market (USD Millions), (2013-2015)
• Figure 4: Postmenopausal Vaginal Atrophy Global Market (USD Millions), (2016-2023)
• Figure 5: Postmenopausal Vaginal Atrophy US Market (USD Millions), (2013-2015)
• Figure 6: Postmenopausal Vaginal Atrophy US Market (USD Millions), (2016-2023)
• Figure 7: Postmenopausal Vaginal Atrophy Germany Market (USD Millions), (2013-2015)
• Figure 8: Postmenopausal Vaginal Atrophy Germany Market (USD Millions), (2016-2023)
• Figure 9: Postmenopausal Vaginal Atrophy United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Postmenopausal Vaginal Atrophy United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Postmenopausal Vaginal Atrophy France Market (USD Millions), (2013-2015)
• Figure 12: Postmenopausal Vaginal Atrophy France Market (USD Millions), (2016-2023)
• Figure 13: Postmenopausal Vaginal Atrophy Italy Market (USD Millions), (2013-2015)
• Figure 14: Postmenopausal Vaginal Atrophy Italy Market (USD Millions), (2016-2023)
• Figure 15: Postmenopausal Vaginal Atrophy Spain Market (USD Millions), (2013-2015)
• Figure 16: Postmenopausal Vaginal Atrophy Spain Market (USD Millions), (2016-2023)
• Figure 17: Postmenopausal Vaginal Atrophy Japan Market (USD Millions), (2013-2015)
• Figure 18: Postmenopausal Vaginal Atrophy Japan Market (USD Millions), (2015-2023)
• Figure 19: Postmenopausal Vaginal Atrophy ROW Market (USD Millions), (2013-2015)
• Figure 20: Postmenopausal Vaginal Atrophy ROW Market (USD Millions), (2016-2023)
• Novo A/S
• Shionogi & Co. Ltd.
• Quatrx Pharmaceutical Company
• Hormos Medical
• Pfizer Inc.
• Italfarmaco S.p.A.
• Duramed Research Inc.
• Allergan Plc
• Abbott Laboratories
• A+ Science AB
